← Leaderboards
Raymond C Koehler
Medical College Of Wisconsin
$25,438,173
Attributed
$29,762,111
Total exposure
15
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$29,762,111 · 15
By mechanism
R01$18,834,384 · 7
P01$7,454,343 · 3
UH3$1,269,751 · 1
U01$1,057,557 · 1
R21$691,125 · 2
UG3$454,951 · 1
Top collaborators
- Emad M Boctor5 shared
- Ted M. Dawson5 shared
- Ernest Marshall Graham5 shared
- Jinyuan Zhou5 shared
- Harikrishna Tandri2 shared
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- David R Harder$18,930,514
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainInjuryInhibitor/AntagonistStrokeSignal TransductionNeuronsBaseProteinsCellsOxidative StressIschemiaHemoglobinRattusAttenuatedInsightLeadBrain InjuriesDisabilityPharmaceutical PreparationsTissuesExcitotoxicityResponseProductionAnimal Model
Grant awards (76)
Wnt Signaling in Stroke$459,301
R01 · FY2022 · NS · contact PI
Development of Novel Functional Markers for TBI Using Molecular MRI$416,273
UH3 · FY2022 · NS
Wnt Signaling in Stroke$463,354
R01 · FY2021 · NS · contact PI
Preclinical stroke trial with the PARP inhibitor veliparib$462,066
U01 · FY2021 · NS · contact PI
Microglia/macrophage polarization after intracerebral hemorrhage$450,874
R01 · FY2021 · NS · contact PI
Development of real-time, non-invasive photoacoustic imaging to rapidly detect and track perinatal focal stroke at birth$421,093
R01 · FY2021 · HL · contact PI
Development of Novel Functional Markers for TBI Using Molecular MRI$420,672
UH3 · FY2021 · NS
Development of real-time, non-invasive photoacoustic imaging to rapidly detect and track perinatal focal stroke at birth$517,633
R01 · FY2020 · HL · contact PI
Preclinical stroke trial with the PARP inhibitor veliparib$472,678
U01 · FY2020 · NS · contact PI
Wnt Signaling in Stroke$471,091
R01 · FY2020 · NS · contact PI
Microglia/macrophage polarization after intracerebral hemorrhage$454,927
R01 · FY2020 · NS · contact PI
Development of Novel Functional Markers for TBI Using Molecular MRI$432,806
UH3 · FY2020 · NS
Development of real-time, non-invasive photoacoustic imaging to rapidly detect and track perinatal focal stroke at birth$511,523
R01 · FY2019 · HL · contact PI
Wnt Signaling in Stroke$474,209
R01 · FY2019 · NS · contact PI
Microglia/macrophage polarization after intracerebral hemorrhage$454,927
R01 · FY2019 · NS · contact PI
Therapeutic Strategies for Neonatal Hypoxic-Ischemiic Encephalopathy$413,720
R01 · FY2019 · NS · contact PI
Development of real-time, non-invasive photoacoustic imaging to rapidly detect and track perinatal focal stroke at birth$408,993
R01 · FY2019 · HL · contact PI
Development of Novel Functional Markers for TBI Using Molecular MRI$397,112
UG3 · FY2019 · NS
Inhibition of ferroptosis after intracerebral hemorrhage$245,625
R21 · FY2019 · NS · contact PI
Preclinical stroke trial with the PARP inhibitor veliparib$122,813
U01 · FY2019 · NS · contact PI
Development of Novel Functional Markers for TBI Using Molecular MRI$57,839
UG3 · FY2019 · NS
Development of real-time, non-invasive photoacoustic imaging to rapidly detect and track perinatal focal stroke at birth$505,042
R01 · FY2018 · HL · contact PI
Therapeutic Strategies for Neonatal Hypoxic-Ischemiic Encephalopathy$413,720
R01 · FY2018 · NS · contact PI
Therapeutic Strategies for Neonatal Hypoxic-Ischemiic Encephalopathy$413,720
R01 · FY2017 · NS · contact PI
Use of transnasal air flow to cool and protect the brain after pediatric cardiac arrest$202,500
R21 · FY2017 · NS · contact PI
Therapeutic Strategies for Neonatal Hypoxic-Ischemiic Encephalopathy$413,720
R01 · FY2016 · NS · contact PI
Use of transnasal air flow to cool and protect the brain after pediatric cardiac arrest$243,000
R21 · FY2016 · NS · contact PI
Therapeutic Strategies for Neonatal Hypoxic-Ischemiic Encephalopathy$413,720
R01 · FY2015 · NS · contact PI
Poly (ADP-Ribose) and AIF in Neuronal Injury$663,037
R01 · FY2014 · NS
Cell Free O2 Carriers: Cerebrovascular Control and Stroke$348,059
R01 · FY2014 · NS · contact PI
Poly (ADP-Ribose) and AIF in Neuronal Injury$646,293
R01 · FY2013 · NS
Cell Free O2 Carriers: Cerebrovascular Control and Stroke$339,270
R01 · FY2013 · NS · contact PI
Poly (ADP-Ribose) and AIF in Neuronal Injury$669,735
R01 · FY2012 · NS
Cell Free O2 Carriers: Cerebrovascular Control and Stroke$351,575
R01 · FY2012 · NS · contact PI
Therapeutic Strategies for Neonatal Hypoxic-Ischemic Encephalopathy$351,575
R01 · FY2012 · NS · contact PI
Poly (ADP-Ribose) and AIF in Neuronal Injury$669,733
R01 · FY2011 · NS
Cell Free O2 Carriers: Cerebrovascular Control and Stroke$351,575
R01 · FY2011 · NS · contact PI
Therapeutic Strategies for Neonatal Hypoxic-Ischemic Encephalopathy$351,575
R01 · FY2011 · NS · contact PI
Poly (ADP-Ribose) and AIF in Neuronal Injury$676,498
R01 · FY2010 · NS
Cell Free O2 Carriers: Cerebrovascular Control and Stroke$358,750
R01 · FY2010 · NS · contact PI
Therapeutic Strategies for Neonatal Hypoxic-Ischemic Encephalopathy$355,163
R01 · FY2010 · NS · contact PI
Cell Free O2 Carriers: Cerebrovascular Control and Stroke$82,000
R01 · FY2010 · NS · contact PI
Role of EETs in Vascular Response to Neural Activation$584,783
P01 · FY2009 · HL · contact PI
Therapeutic Strategies for Neonatal Hypoxic-Ischemic Encephalopathy$358,750
R01 · FY2009 · NS · contact PI
Therapeutic Strategies for Neonatal Hypoxic-Ischemic Encephalopathy$99,952
R01 · FY2009 · NS · contact PI
Role of EETs in Vascular Response to Neural Activation$557,291
P01 · FY2008 · HL · contact PI
Molecular Mechanisms of PARP-Dependent Cell Death in Stroke$451,248
P01 · FY2008 · NS · contact PI
Therapeutic Strategies for Neonatal Hypoxic-Ischemic Encephalopathy$358,750
R01 · FY2008 · NS · contact PI
Cell-Free O2 Carriers: Cerebrovascular Control & Stroke$358,502
R01 · FY2008 · NS · contact PI
Role of EETs in Vascular Response to Neural Activation$516,716
P01 · FY2007 · HL · contact PI
Molecular Mechanisms of PARP-Dependent Cell Death in Stroke$473,929
P01 · FY2007 · NS · contact PI
Cell-Free O2 Carriers: Cerebrovascular Control & Stroke$358,502
R01 · FY2007 · NS · contact PI
Cardiac Arrest/CPR: Mechanisms of Brain Injury in The Newborn$229,521
P01 · FY2007 · NS · contact PI
Role of EETs in Vascular Response to Neural Activation$536,167
P01 · FY2006 · HL · contact PI
Cell-Free O2 Carriers: Cerebrovascular Control & Stroke$369,209
R01 · FY2006 · NS · contact PI
Molecular Mechanisms of PARP-Dependent Cell Death in Stroke$343,352
P01 · FY2006 · NS · contact PI
Cardiac Arrest/CPR: Mechanisms of Brain Injury in The Newborn$239,961
P01 · FY2006 · NS · contact PI
Role of EETs in Vascular Response to Neural Activation$545,862
P01 · FY2005 · HL
Cell-Free O2 Carriers: Cerebrovascular Control &Stroke$378,094
R01 · FY2005 · NS
Molecular Mechanisms of PARP-Dependent Cell Death in Stroke$343,350
P01 · FY2005 · NS
Cardiac Arrest/CPR: Mechanisms of Brain Injury in The Newborn$237,763
P01 · FY2005 · NS
Cell-Free O2 Carriers: Cerebrovascular Control &Stroke$378,094
R01 · FY2004 · NS
Molecular Mechanisms of PARP-Dependent Cell Death in Stroke$343,352
P01 · FY2004 · NS
Cardiac Arrest/CPR: Mechanisms of Brain Injury in The Newborn$232,778
P01 · FY2004 · NS
CELL-FREE 02 CARRIERS: CEREBROVASCULAR CONTROL &STROKE$504,073
R01 · FY2003 · NS
Cardiac Arrest/CPR: Mechanisms of Brain Injury in The Newborn$247,285
P01 · FY2003 · NS
CELL-FREE 02 CARRIERS: CEREBROVASCULAR CONTROL &STROKE$491,433
R01 · FY2002 · NS
CYTOCHROME P450A EPOXYGENASE ACTIVITY IN CEREBRAL CIRCULATORY RESPONSE$282,412
P01 · FY2002 · HL
DEVELOPMENTAL CEREBROVASCULAR REGULATION IN THE FETUS AND NEWBORN$255,866
P01 · FY2002 · NS
CELL-FREE 02 CARRIERS: CEREBROVASCULAR CONTROL &STROKE$477,879
R01 · FY2001 · NS
CYTOCHROME P450A EPOXYGENASE ACTIVITY IN CEREBRAL CIRCULATORY RESPONSE$282,412
P01 · FY2001 · HL
DEVELOPMENTAL CEREBROVASCULAR REGULATION IN THE FETUS AND NEWBORN$255,866
P01 · FY2001 · NS
CELL-FREE 02 CARRIERS: CEREBROVASCULAR CONTROL &STROKE$480,482
R01 · FY2000 · NS
CEREBROVASCULAR ALTERATIONS DURING HYPERAMMONEMIA$344,259
R01 · FY2000 · NS
CYTOCHROME P450A EPOXYGENASE ACTIVITY IN CEREBRAL CIRCULATORY RESPONSE$339,485
P01 · FY2000 · HL
DEVELOPMENTAL CEREBROVASCULAR REGULATION IN THE FETUS AND NEWBORN$154,944
P01 · FY2000 · NS